Eu Ivdr Eu Ivd Class A On The Market 🇩🇪 Germany

cerascreen® COVID-19 Vaccine Effectiveness Test

Cerascreen GmbH · 🇩🇪 Germany
Devices (same UDI-DI)
100
Certificates
0
Countries
9
Notified Bodies
0

Basic Information

Primary DI
04251620706483
Basic UDI-DI Code
42516207002JR
Reference
99010445
Device Types
Single use
Regulation
Eu Ivdr
Classification
Eu Ivd Class A
Status
On The Market
Manufacturer
Cerascreen GmbH

Additional Description

The cerascreen® COVID-19 Vaccine Effectiveness Test is a send-in sample-taking kit that can identify S1 IgG and NP IgG antibodies. Have your blood checked for antibodies following your vaccination against SARS-CoV-2. Please note: The cerascreen® COVID-19 Vaccine Effectiveness Test is not suitable for detecting an acute infection. The test is used to identify the presence of antibodies after receiving a vaccination.

CND Nomenclature Codes

Code Description
W0501010201 CAPILLARY BLOOD COLLECTION SYSTEMS

Available In Countries

🇦🇹 Austria 🇩🇪 Germany 🇩🇰 Denmark 🇪🇸 Spain 🇫🇷 France 🇮🇹 Italy 🇳🇱 Netherlands 🇳🇴 Norway 🇸🇪 Sweden

Related Devices

The Basic UDI-DI associated with this device has 100 devices in total. Below are some other devices sharing the same Basic UDI-DI.

Similar Devices

Other on-the-market devices with the same classification (Eu Ivd Class A) and regulation (EU IVDR).

View all